11 - 17 January 2020
These are links to news stories about multiple sclerosis from the last week that may be of interest to people affected by MS in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter, or regular email alerts.
Ocrevus approved for PPMS in Scotland
The Scottish Medicines Consortium (SMC) has approved Ocrevus as a treatment for people with early, inflammatory primary progressive MS (PPMS). This brings Scotland into line with England, where the drug was approved last year.
MS Trust link: Ocrevus for primary progressive MS: What you need to know
Languages help protect cognition
Bilingual people with MS had better cognition (thinking and memory) scores than people who only speak one language, according to research carried out in Spain. A separate small study in Austria found that learning a second language may help reduce cognition problems. The studies demonstrate the importance of building up cognitive reserve to counteract the effects of MS
MS Trust link: Cognitive reserve
MS progression affected by timing of DMD treatment
People with clinically isolated syndrome (CIS) who started disease modifying drug treatment after their first relapse had a higher chance of a lower levels of disability in the longer-term than people who delayed treatment, according to a US study.
Source: MS News Today
MS Trust link: MS Decisions - a guide to disease modifying drugs for relapsing MS
When does MS start?
People who subsequently develop MS show higher levels of a marker for damage to the nervous system (neurofilament light chain) up to six years before onset of the condition, according to a US study that studied blood samples from military personnel. None had symptoms at the time the blood was collected
Source: National MS Society (USA)
MS Trust link: How is MS diagnosed?
MS in the Media
20 Nov 2020 - 00:00
- New study for advanced MS
- Campaign for fair benefits during the pandemic
- Stem cells compared to Lemtrada
- DMD use and finances
David Martin appointed Chair of the Neurological Alliance
18 Nov 2020 - 00:00
The MS Trust is delighted to announce that CEO David Martin, has been voted in as Chair of the Neurological Alliance.
My MS and my mental health
16 Nov 2020 - 00:00
In his latest blog, Ian Daly speaks candidly about his own experience with depression and urges others to seek help if needed.